To present a modified technique in artificial urinary sphincter (AUS) placement that is associated with low rates of erosion and infection in a high-risk population.
Introduction
Since its introduction in the 1970s, the artificial urinary sphincter (AUS) has been the benchmark of the management of stress urinary incontinence (UI), especially for men who have undergone a radical prostatectomy. Its design has had incremental modifications since then. The most important of which was the introduction of the narrow-back cuff, which led to significantly lower re-operation rates [1] . More recently, the addition of an antibiotic coating has been thought to decrease infection rates, and the introduction of a smaller diameter cuff possibly thought to improve effectiveness [2] .
Despite these modifications, the cuff-insertion technique has remained stable consisting of a midline perineal approach to the bulbar urethra [3] . This is similar to the familiar dissection of a proximal urethroplasty; that is, midline division of the bulbospongiosus muscle with direct dissection on the urethral bulb to encircle it. Whilst encircling the urethra, however, the surgeon encounters its dorsal aspect, which is the thinnest and at greatest risk of intraoperative urethral damage, with possible later cuff erosion. In fact, early device infection is often associated with underlying, often unrecognised, cuff erosion. Erosion and infection lead to an additional operation to explant the device followed by a period of several months during which time the patient is incontinent, and finally an operation to place another device. This is distinct from a device replacement for malfunction or inadequate continence, in which case the device can be removed and replaced in the same setting, thereby reducing the time that the patient is incontinent and decreasing the number of operations the patient undergoes. Furthermore, AUS outcomes are worse in patients who have a history of erosion, and some men never undergo repeat AUS replacement because of the newly formed urethral stricture. Therefore, our major focus in performing the AUS procedure is to decrease infection and erosion rates.
We changed our AUS surgical technique in 2007 because we hypothesised that we could mitigate the risk of erosion, whilst maintaining effectiveness, by modifying our technique for placement of the urethral cuff. We use a dissection that avoids initial bisection of the urethral bulb away from the bulbospongiosus muscle. The dissection begins by encircling the entire bulbar urethra, the bulb, and the bulbospongiosus muscle and thereby avoids direct dorsal dissection of the urethra. This preserves the dorsolateral fibromuscular tissue. We then dissect the ventral bulbospongiosus muscle away from the urethral bulb to allow closer apposition of the cuff to the urethra. The aim is to decrease complications, specifically erosion and infection, whilst maintaining effectiveness. In the present study, we provide our results with this approach.
Patients and Methods
After obtaining Institutional Review Board approval, we queried our prospectively maintained database to identify all consecutive male patients who underwent primary insertion of an AUS at our institution. We excluded patients with a prior history of male sling placement or those with previous AUS placement. Patients who underwent transcorporeal or tandem cuff placement were also excluded. There were 208 patients between January 2007 and November 2015 that met the criteria for analysis.
We used Kaplan-Meier methods to estimate the rate of 'any' re-operation and the rate of re-operation due to infection or erosion after AUS insertion performed at the Memorial Sloan Kettering Cancer Center. Cox proportional hazards regression was used to assess whether prior radiotherapy (RT) or type of RT (primary or salvage) was associated with time to reoperation. Men were considered continent at 1 year, if they reported using 0/1 pad/day at 9-15 months after operation, and not continent if they reported using ≥2 pads/day or required a re-operation within 1 year of insertion. All analyses were conducted using Stata 13.0 (StataCorp, College Station, TX, USA).
Surgical Technique
All procedures during the study period were undertaken using our 'modified technique' for cuff placement. Patients had preoperative video-urodynamics (as per ICS standards) cystoscopy to exclude urothelial pathology, aberrant anatomy, or anastomotic strictures [4] . If an anastomotic stricture was discovered, it was dilated, incised, or resected, until stable prior to insertion of the AUS. This step-wise management of bladder neck contractures has been previously described elsewhere [5] . There were no patients who underwent treatment for anastomotic stricture simultaneously with AUS placement. All patients received perioperative antibiotics, with vancomycin 1 g 9 two doses and gentamicin 3 mg/kg, unless the patient had renal insufficiency in which case vancomycin was renally dosed and gentamicin was substituted with ceftazidime 2 mg i.v.
Our modified technique involves placing a 14-F urethral catheter with a drainage bag already attached followed by a standard midline perineal incision. Sharp dissection is continued outside the bulbospongiosus muscle until the corporal bodies are encountered (Fig. 1) , which are then dissected free from the bulbospongiosus muscle to the level of the inferior pubic ramus. Here, the bulbospongiosus muscle (bulbar urethra contained within) and fibromuscular layers of the perineal membrane are encircled under vision with the use of a right-angle clamp (Fig. 2) . The muscle is then transversely divided at its ventral aspect ( Fig. 3 ) to expose the urethral bulb ensuring that the dorsal bulbospongiosus muscle is intact and the fibromuscular layers of the perineal membrane are included (Fig. 4A,B ). The urethral circumference is then measured using a measuring tape ( Fig. 5 ) and the cuff is placed around the ventral bulbar urethra including the dorsolateral fibromuscular layers (Fig. 6A,B) . After cuff placement, the ventral bulbospongiosus muscle is re-approximated over the secured urethral cuff with a running suture.
A sub-rectus space is created via a counter incision for the ectopic placement of the pressure-regulating balloon (Fig. 7) . The urethral catheter is removed on postoperative day 1, and the patient is discharged after a successful voiding trial. If postoperative retention is noted, a 12-F Foley is gently reinserted and a further voiding trial is undertaken~2 days later. The patient is discharged with analgesia and appropriate prophylactic antibiotics.
The patient is seen at 2 weeks after AUS placement for wound review and the device is activated at 6 weeks postoperatively. Long-term follow-up is at 3, 6, 12 months, and yearly thereafter. At any time during the follow-up if there is a change in symptoms or recurrence of UI, an evaluation is initiated including cystoscopy to identify problems such as erosion.
Results
The study cohort included 208 patients with AUS insertion procedures performed by a single surgeon. There were 58 reoperations for 'any' reason. The median (interquartile range [IQR]) follow-up time after first AUS for patients with no reoperation was 2.4 (1.0-4.3) years. The majority of patients had had a previous radical prostatectomy (84%) and 40% of patients had had RT to the prostate before their first AUS procedure. Notably, 32 patients (15%) had had RT prior to prostatectomy (Table 1) .
Reasons for re-operation were categorised as due to erosion in six (2.9%) patients, device malfunction/mechanical issues in 21 patients, and other reasons, which included decreased effectiveness or residual UI or recurrent anastomotic stricture in 31 patients. Amongst the six re-operations due to erosion, two were due to skin erosions: a tubing erosion in the scrotum in a patient on androgen-deprivation therapy and a scrotal pump erosion in a patient that underwent scrotal surgery for an unrelated condition. Two were due to erosion after instrumentation, one after catheterisation and one after cystoscopy, and two were presumably spontaneous urethral erosions. There were no AUS infections in the study cohort, and therefore no re-operations for infection. The probability of re-operation for 'any' reason was 7% (95% CI 4-12%) at 1 year and 17% (95% CI 12-23%) at 2 years. For re-operation due to erosion or device malfunction, the probability was 2% (95% CI 1-6%) at 1 year and 6% (95% CI 3-11%) at 2 years. Kaplan-Meier estimates for time to re-operation due to infection, erosion or device malfunction are presented in Fig. 8 . Using a Cox proportional hazards model, we found no evidence of an association between history of prior RT or type of RT and time to re-operation for 'any' reason (Table 2) .
Whilst AUS failure was considered a complication that required re-operation, six patients had other complications that did not require re-operation within 30 days of surgery, with one case each of pulmonary embolus, bladder neck contracture, scrotal haematoma, abdominal haematoma, postoperative fever, and urinary retention due to difficulty using the device. Furthermore, there were 22 patients (out of 208, 11%) who had self-limited postoperative urinary retention that resolved spontaneously after a further 2 days of catheterisation.
Men were considered socially continent at 1 year after operation if they reported using 0/1 pad/day, and were considered not socially continent if they reported using ≥2 pads/day or required a re-operation within that 1-year period. At 1 year after AUS placement, the probability of being socially continent was 74% (95% CI 67-81%) amongst the 170 patients with continence outcomes available.
Discussion
We describe a technique in which the dorsal dissection of the urethra remains outside the bulbospongiosus muscle, whilst including dorsolateral fibromuscular tissue in the cuff placement. We report low rates of re-operation and excellent long-term continence.
Roth et al. [6] describe placement of the cuff around the entire bulbospongiosus muscle. This involved a similar initial dissection, but was associated with increased revision rates, probably due to muscle atrophy under the cuff. More recently, Collado Serra et al. [7] reported their results using a bulbospongiosus muscle-preserving technique, which included dorsal urethral dissection similar to our present technique. They reported their results on 82 patients over an 11-year period, reporting a 77% dry rate at 1 year and, notably, only one erosion during the that time. Our present technique differs in that while the initial dissection is similar, we transect the ventral portion of the bulbospongiosus muscle overlying the thickest part of the urethral bulb, to allow better sizing of the cuff. This in turn allows for optimised effectiveness of sphincter coaptation and minimisation of erosions by preserving the dorsal layer of fibromuscular tissue. Erosions are devastating complications, especially in high-risk populations (i.e. patients who have undergone RT), and manoeuvres to prevent this are extremely useful.
Guralnick et al. [8] popularised the placement of a transcorporeal cuff in order to avoid dissection of the dorsal urethra, especially in revision surgery, and particularly after a previous cuff erosion. This technique is associated with increased rates of erectile dysfunction and haematomas due to the corporotomies, and relies on using a part of the urethra distal to the normal perineal location because the cuff has to be placed at a location where the corpora have not bifurcated. Other techniques for cuff placement, including tandem cuffs and penoscrotal approaches, have been described but these do not protect the dorsal urethra [9] . At our institution, transcorporeal or tandem cuff placement is not done at the time of initial AUS placement and therefore these patients were not included in the present study cohort.
Gousse et al. [10] reported long-term patient-reported outcomes and noted an infection rate of 1.4% and erosion rate of 4%. Whilst our present median follow-up time without requiring re-operation is 2.4 years, past large series showed that infection and erosion rates tend to occur earlier. Lai et al. reported their results with AUS placement in 218 high-risk patients over 13 years, 28% of whom had had previous RT, and noted an infection rate of 5.5% and an erosion rate of 6%. Infections in their series occurred at a median of 3.7 months and erosions at a median of 19.8 months [11] . We think that the prevention of urethral cuff erosion is paramount during AUS surgery. This is not only because of the increased burden of urgent secondary surgery to remove the AUS, but also because of the 3-6 month period of UI that these patients have to endure. Furthermore, results of revision surgery after erosion are worse than those with primary surgery [12] , and in some series <50% of patients ultimately receive a secondary AUS after erosion [13] . The overall erosion rate in our present series was 2.9%, but the incidence of spontaneous urethral cuff erosion was extremely low (two of 208, 0.9%, of all primary AUS cases). There were two cases with erosions associated with documented instrumentation of the urethra. This is not surprising considering the main strength of our present technique is to protect the dorsal urethra during dissection. It also reminds us that further education of health professionals about the risk of careless catheterisation of an activated AUS is needed. We have previously advocated the use of 'medical alert' bracelets for patients with an AUS to help in this regard [14] .
We had no infections in our present series. This is probably due to the use of meticulous surgical technique, ensuring no breaks in the sterility, and using appropriate perioperative antibiotics, but also due to the fact that we had no early erosions or unrecognised urethral injuries. Erosion is often also associated with infection. In fact, some authorities believe that early erosion will present as an infection. We suspect that this is the main reason that we had no cases of infection in our present cohort -specifically, early or 'technical' erosion rates are decreased by including the dorsolateral fibromuscular tissue within the urethral cuff. This is in comparison with published infection rates of 3-16% [15] .
Our present study population is a complex group of patients. Many had been referred from outside institutions with the majority having had attempts at urethral bulking and some with known metastatic prostate cancer on androgen blockade. About40% of our present patient cohort had undergone RT and >25% required prior surgery for bladder neck contractures. Of note, 15% of our present patients had had a salvage prostatectomy -prostatectomy for local recurrence often many years after primary RT. This subset of patients is known to have high rates of UI and anastomotic stricture [16] . These more complex patients did not require any alteration of our present technique, which is a significant advantage.
Similar to other published studies [15, 17, 18] , prior RT does not appear to adversely affect continence outcomes or increase complications. This may be an advantage of our present technique in that the initial wide dissection avoids the chance of damaging the urethra. The dissection also is more within avascular tissue planes and involves relatively minimal bleeding.
The main reason for an AUS is to improve urinary continence. Whilst different measures have been used to measure urinary continence (pad numbers, pad weight, specific questionnaires, entirely dry), social continence (use of 0/1 pad/day) is considered technical success by most authorities and used to compare different techniques. Our present series had a 74% continence rate at 1 year after AUS placement. Patients who required re-operation within 1 year were considered to be and included in the 'not socially continent' group. This rate of continence is similar to published series, which are reported to be between 61% and 100% [19] . Meta-analysis of published series report a continence improvement in 88% and total continence of 74% but with urethral erosion and infection rates of 12% and 4.5%, respectively, using a traditional surgical approach [20] .
More recently, O'Connor et al. [21] reported in a series of 33 elderly men aged >75 years a success rate of 72% using 0/1 pad/day, and device removal for erosion in two (11%) patients. None of those patients receiving the AUS had had a salvage prostatectomy, which again is considered high-risk for perioperative complications. Our present study, with the modified technique, has a low erosion rate and at the same time allows for good efficacy in a population of high-risk patients where complications, like erosions and infections, are devastating morbidities.
The major limitation of the present study is the retrospective nature of the analysis, and thus may have inherent selection bias. Nevertheless, the analysis is on consecutive patients undergoing primary AUS placement and excluding any patients that had had prior stress UI procedures. Additionally, outcomes are patients from a single centre and a single surgeon, which may limit reproducibility. The learning curve for AUS placement has been shown to be steep and significant (25 up to 200 cases) [22, 23] . Furthermore, there are no direct comparisons of AUS cuff-placement techniques in the literature [24] . It is extremely difficult to perform such a comparison given the limited number of AUS cases performed each year, even at high-volume centres.
Conclusion
Our modified technique is safe with low infection and erosion rates and functional outcomes comparable to contemporary series, despite our relatively high-risk population. The low rate of infection and erosion is particularly notable because of the high burden on patients who endure these complications -two additional operations and lower success rate than in patients without infection or erosion. Our technique can be Number at risk Proportion of study cohort used across a wide variety of patients, including those with a history of RT and bladder neck contracture.
